Testicular germ-cell cancer

Alan Horwich1, Janet Shipley, Robert Huddart

  • 1Institute of Cancer Research and Royal Marsden NHS Foundation Trust, Surrey SM2 5PT, UK. alan.horwich@icr.ac.uk

PubMed

Insights

Testicular germ-cell tumors (TGCTs) are highly curable cancers. Advances focus on tailoring treatment to prognosis, reducing chemotherapy for good-prognosis metastatic non-seminomas and offering alternatives to radiotherapy for stage I seminomas.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cancer Therapeutics

Background:

  • Testicular germ-cell tumors (TGCTs) are a model for curable malignancies.
  • Understanding TGCT molecular biology may inform other cancer treatments.
  • Management must consider long-term toxicity in young adults.

Purpose of the Study:

  • To summarize recent advances in TGCT understanding and management over the past decade.
  • To highlight the tailoring of treatment aggressiveness based on prognostic severity.
  • To review changes in managing common TGCT subtypes.

Main Methods:

  • Review of recent developments in testicular germ-cell tumor management.
  • Analysis of changes in chemotherapy protocols for metastatic non-seminomas.
  • Evaluation of alternatives to adjuvant radiotherapy for stage I seminomas.

Main Results:

  • Reduced chemotherapy is now recommended for metastatic non-seminomas with a good prognosis.
  • Alternatives to adjuvant radiotherapy are available for stage I seminomas.
  • Treatment strategies are increasingly tailored to individual patient prognosis.

Conclusions:

  • Testicular germ-cell tumors represent a highly curable malignancy with evolving treatment paradigms.
  • Recent advances focus on reducing treatment intensity and toxicity.
  • Personalized management based on prognosis is improving TGCT outcomes.

Related Concept Videos

Cancer02:18

Cancer

Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
Cancers Originate from Somatic Mutations in a Single Cell02:21

Cancers Originate from Somatic Mutations in a Single Cell

Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
Cancer Stem Cells and Tumor Maintenance02:40

Cancer Stem Cells and Tumor Maintenance

Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancers Originate from Somatic Mutations in a Single Cell02:21

Cancers Originate from Somatic Mutations in a Single Cell

Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
Disorders of the Male Reproductive System01:20

Disorders of the Male Reproductive System

Men's health issues are increasingly recognized as significant, with several conditions posing common threats. Among these, testicular cancer is especially prevalent in younger men, particularly those aged 20 to 35 years. The disease often manifests as a painless mass in the testicles, sometimes accompanied by a sensation of heaviness or a dull ache.
Prostate disorders are another major concern. These conditions can impair urinary flow due to the prostate's location around the urethra. Symptoms...